Poliovirus has a single-stranded RNA genome of positive polarity that serve
s two essential functions at the start of the viral replication cycle in in
fected cells. First, it is translated to synthesize viral proteins and, sec
ond, it is copied by the viral polymerase to synthesize negative-strand RNA
. We investigated these two reactions by using HeLa S10 in vitro translatio
n-RNA replication reactions. Preinitiation RNA replication complexes were i
solated from these reactions and then used to measure the sequential synthe
sis of negative- and positive-strand RNAs in the presence of different prot
ein synthesis inhibitors. Puromycin was found to stimulate RNA replication
overall. In contrast, RNA replication was inhibited by diphtheria toxin, cy
cloheximide, anisomycin, and ricin A chain. Dose-response experiments showe
d that precisely the same concentration of a specific drug was required to
inhibit protein synthesis and to either stimulate or inhibit RNA replicatio
n This suggested that the ability of these drugs to affect RNA replication
was linked to their ability to alter the normal clearance of translating ri
bosomes from the input viral RNA. Consistent with this idea was the finding
that the protein synthesis inhibitors had no measurable effect on positive
strand synthesis in normal RNA replication complex-es. In marked contrast,
negative-strand synthesis was stimulated by puromycin and was inhibited by
cycloheximide. Puromycin causes polypeptide chain termination and induces
the dissociation of polyribosomes from mRNA, Cycloheximide and other inhibi
tors of polypeptide chain elongation "freeze" ribosomes on mRNA and prevent
the normal clearance of ribosomes from viral RNA templates. Therefore, it
appears that the poliovirus polymerase a-as not able to dislodge translatin
g ribosomes from viral RNA templates and mediate the switch from translatio
n to negative-strand synthesis. Instead, the initiation of negative-strand
synthesis appears to be coordinately regulated with the natural clearance o
f translating ribosomes to avoid the dilemma of ribosome-polymerase collisi
ons.